MedAvail Pharmacy Kiosk
Automated pharmacy dispensing kiosk for convenient medication access
Company profile
Company profile
MedAvail is a healthcare technology company that operates automated pharmacy dispensing systems designed to improve medication access and adherence. The company deploys intelligent pharmacy kiosks that combine robotics, telepharmacy, and AI-driven technology to provide prescription fulfillment services in convenient locations including hospitals, clinics, retail stores, and underserved areas. MedAvail's platform enables patients to pick up medications at any time through self-service kiosks while maintaining pharmacist oversight via telehealth connections. The company's solution addresses medication access barriers by extending pharmacy services beyond traditional hours and locations, particularly benefiting rural and underserved populations. MedAvail's technology integrates with existing pharmacy workflows and electronic health record systems to streamline prescription processing, reduce wait times, and improve patient convenience. The automated dispensing units are designed to handle a wide range of medications while ensuring security, accuracy, and compliance with pharmacy regulations. By combining automation with remote pharmacist consultation capabilities, MedAvail aims to modernize medication distribution while maintaining the clinical oversight and patient counseling that traditional pharmacy services provide.
Company description MedAvail official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
On Premise deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Automated pharmacy dispensing kiosk for convenient medication access
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Cell and tissue research · Nov 1, 2019
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Extended pharmacy service hours through automated kiosks
Serving underserved and rural communities
Automated prescription fulfillment
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on MedAvail's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.